Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Guardant Blood Test Works as Well as Biopsy in Lung Cancer Care

Feb. 28, 2019, 2:40 PM

Time is of the essence for lung cancer patients, and new results from a study of Guardant Health’s blood test showed that Guardant360 is as accurate as a standard biopsy in identifying biomarkers of the disease -- while getting back results in less time.

Among the 282 newly diagnosed patients with advanced lung cancer in the study, Guardant360’s sequencing technology was able to identify cancer biomarkers in 77 patients by itself, while tissue biopsies found 60. These biomarkers can be key in steering patients toward new precision medicines that target specific tumor mutations and improve a patient’s odds of survival. ...